Cargando…

Role of Hydroxyapatite and Ellagic Acid in the Osteogenesis

Objective  Ellagic acid (EA), a phenolic antioxidant, has benefits in bone health and wound healing. The combination of EA and hydroxyapatite (HA) (EA-HA) is expected to increase osteogenesis. The aim of this study was to analyze osteogenesis after application of EA-HA according to the number of ost...

Descripción completa

Detalles Bibliográficos
Autores principales: Wardhana, Agung Satria, Nirwana, Intan, Budi, Hendrik Setia, Surboyo, Meircurius Dwi Condro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906838/
https://www.ncbi.nlm.nih.gov/pubmed/32688409
http://dx.doi.org/10.1055/s-0040-1714039
_version_ 1783655373806239744
author Wardhana, Agung Satria
Nirwana, Intan
Budi, Hendrik Setia
Surboyo, Meircurius Dwi Condro
author_facet Wardhana, Agung Satria
Nirwana, Intan
Budi, Hendrik Setia
Surboyo, Meircurius Dwi Condro
author_sort Wardhana, Agung Satria
collection PubMed
description Objective  Ellagic acid (EA), a phenolic antioxidant, has benefits in bone health and wound healing. The combination of EA and hydroxyapatite (HA) (EA-HA) is expected to increase osteogenesis. The aim of this study was to analyze osteogenesis after application of EA-HA according to the number of osteoblasts and osteoclasts in the bone and the expression of the receptor activator of nuclear factor kappa-β ligand (RANKL), osteoprotegerin (OPG), and osteocalcin (OCN) protein. Materials and Methods  Thirty Wistar rats were assessed with bone defects created in the left femur. The defects were filled with EA-HA and then sutured. Control groups were filled with polyethylene glycol (PEG) or HA. Each group was sacrificed either 7 or 14 days after treatment. Results  The defects filled with EA-HA exhibited the highest number of osteoblasts and the greatest expression of OPG and OCN at both day 7 and day 14 ( p = 0.000). Conversely, treatment with EA-HA resulted in lower numbers of osteoclasts and reduced RANKL staining at both time points ( p = 0.000). Conclusions  EA-HA can increase osteogenesis in bone defects by increasing the number of osteoblasts and the expression of OPG and OCN.
format Online
Article
Text
id pubmed-7906838
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79068382021-03-03 Role of Hydroxyapatite and Ellagic Acid in the Osteogenesis Wardhana, Agung Satria Nirwana, Intan Budi, Hendrik Setia Surboyo, Meircurius Dwi Condro Eur J Dent Objective  Ellagic acid (EA), a phenolic antioxidant, has benefits in bone health and wound healing. The combination of EA and hydroxyapatite (HA) (EA-HA) is expected to increase osteogenesis. The aim of this study was to analyze osteogenesis after application of EA-HA according to the number of osteoblasts and osteoclasts in the bone and the expression of the receptor activator of nuclear factor kappa-β ligand (RANKL), osteoprotegerin (OPG), and osteocalcin (OCN) protein. Materials and Methods  Thirty Wistar rats were assessed with bone defects created in the left femur. The defects were filled with EA-HA and then sutured. Control groups were filled with polyethylene glycol (PEG) or HA. Each group was sacrificed either 7 or 14 days after treatment. Results  The defects filled with EA-HA exhibited the highest number of osteoblasts and the greatest expression of OPG and OCN at both day 7 and day 14 ( p = 0.000). Conversely, treatment with EA-HA resulted in lower numbers of osteoclasts and reduced RANKL staining at both time points ( p = 0.000). Conclusions  EA-HA can increase osteogenesis in bone defects by increasing the number of osteoblasts and the expression of OPG and OCN. Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-02 2020-07-20 /pmc/articles/PMC7906838/ /pubmed/32688409 http://dx.doi.org/10.1055/s-0040-1714039 Text en European Journal of Dentistry. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Wardhana, Agung Satria
Nirwana, Intan
Budi, Hendrik Setia
Surboyo, Meircurius Dwi Condro
Role of Hydroxyapatite and Ellagic Acid in the Osteogenesis
title Role of Hydroxyapatite and Ellagic Acid in the Osteogenesis
title_full Role of Hydroxyapatite and Ellagic Acid in the Osteogenesis
title_fullStr Role of Hydroxyapatite and Ellagic Acid in the Osteogenesis
title_full_unstemmed Role of Hydroxyapatite and Ellagic Acid in the Osteogenesis
title_short Role of Hydroxyapatite and Ellagic Acid in the Osteogenesis
title_sort role of hydroxyapatite and ellagic acid in the osteogenesis
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906838/
https://www.ncbi.nlm.nih.gov/pubmed/32688409
http://dx.doi.org/10.1055/s-0040-1714039
work_keys_str_mv AT wardhanaagungsatria roleofhydroxyapatiteandellagicacidintheosteogenesis
AT nirwanaintan roleofhydroxyapatiteandellagicacidintheosteogenesis
AT budihendriksetia roleofhydroxyapatiteandellagicacidintheosteogenesis
AT surboyomeircuriusdwicondro roleofhydroxyapatiteandellagicacidintheosteogenesis